Clinical Trials Directory

Trials / Completed

CompletedNCT03860545

New Markers of Cardiac Surgery Related Acute Kidney Injury.

The New Biochemical Markers of Cardiac Surgery Related Acute Kidney Injury.

Status
Completed
Phase
Study type
Observational
Enrollment
88 (actual)
Sponsor
Pomeranian Medical University Szczecin · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cardiac surgery related acute kidney injury (CS-AKI) is a clinical problem associated with a cardiopulmonary bypass used during cardiac surgery procedures. In this study the investigators will assess the biochemical markers of acute kidney injury such as ischemia modified albumin (IMA) or urinary excreted of brush-border enzymes of the proximal renal tubules perioperatively. There has been no official recommendations toward routine use of analysed biomarkers.

Detailed description

Cardiac surgery related acute kidney injury (CS-AKI) is an important clinical problem. Kidney injury occurs following a cardiopulmonary bypass used during cardiac surgery procedures. The pathomechanisms of acute kidney injury (AKI) is complex and multifactorial. It may involve few injury pathways: ischemia and reperfusion, endogenous toxins, inflammation, metabolic factors and oxidative stress. Biochemical markers of acute kidney injury such as ischemia modified albumin (IMA) or urinary excreted of brush-border enzymes of the proximal renal tubules analysed perioperatively will be assessed in this study. There has been no official recommendations toward routine use of analysed biomarkers.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTurine and blood analysisconcentration of ischemia modified albumin assessed in blood before operation, immediately and one hour after cardiopulmonary bypass, 24 hours after operation; concentration of urinary excretion of brush-border enzymes of the proximal renal tubules assessed before operation, immediately and one hour after cardiopulmonary bypass, 24 hours after operation, serum creatinine levels will be evaluated on the day of the operation and 24 h and 48 h postoperatively

Timeline

Start date
2018-01-02
Primary completion
2019-02-26
Completion
2019-02-26
First posted
2019-03-04
Last updated
2019-03-04

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT03860545. Inclusion in this directory is not an endorsement.